Bayer Aktie News

10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign 10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT® XL® 30 mg tablets1 in Canada. This strategic collaboration took effect on September 3, 2025. “We are excited to partner with Mint Pharmaceuticals Inc., a company known for its commitment to quality and customer service,” said Viktoria Friedr...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)'s Annual Scientific Meeting in Minneapolis, Minnesota, September 26-29, 2025. In July 2025, the U.S. Food and Drug Administration (FDA) approved a new indication for KERENDIA to treat adult p...

Bayer's pioneering cell and gene therapies for Parkinson's disease are at the forefront of an exciting but risky test of CEO Bill Anderson's development credentials as patent expiries on blockbuster drugs threaten the group's long-term growth projects.

Bayer Chief Executive Bill Anderson said the company is making "remarkable progress" in overcoming longstanding challenges, including a weak drug development pipeline, after an internal management overhaul.

Bayer has started the third phase of human testing of an experimental stem cell therapy for Parkinson's disease, with future results potentially underpinning a request for regulatory approval, the company said on Monday.

BERLIN--(BUSINESS WIRE)--Bayer announced today progress for two potential therapies against Parkinson's disease (PD). A first participant received randomized treatment in the pivotal Phase III clinical trial, exPDite-2, of bemdaneprocel, an investigational cell therapy for PD. At the same time, first European participants have been randomized in REGENERATE-PD, a Phase II clinical trial of AB-10...

Bayer's Aspirina – the #1 Pain Relief Option in Mexico – is Now Available in the U.S., Providing a Familiar and Effective Pain Relief Option to Hispanic Communities Bayer's Aspirina – the #1 Pain Relief Option in Mexico – is Now Available in the U.S., Providing a Familiar and Effective Pain Relief Option to Hispanic Communities